The Lancet Regional Health – Southeast Asia
-
1
[Articles] Iodine nutrition, thyroid function, and thyroid autoimmunity four decades after Universal Salt Iodisation in India: a cross-sectional study among schoolchildren (ICMR-SALT-T 1)
-
2
[Articles] Epidemiology of Kyasanur forest disease in India, 2000–2025: a systematic review and meta-analysis
-
3
[Articles] Time to diagnosis of acute kidney injury and its predictors among outborn neonates in India: a competing-risk analysis of tele-ICU network data (2022–2024)
-
4
[Articles] Assessment of health and nutrition status among children aged 5–9 years in Pakistan: a cross-sectional survey (2020)
-
5
[Articles] Prevalence of and factors associated with gestational diabetes mellitus and diabetes in pregnancy in Bangladesh: a facility-based cross-sectional study (2019–2020)
-
6
[Articles] Predicting the status of 35 sustainable development goal indicators in Indian villages: a semi-supervised machine learning approach for precision public policy
-
7
[Articles] Impact of alcohol use on economy of the Association of Southeast Asian Nations member states in 2000–2023: a structural equation modelling analysis
-
8
[Health Policy] Antimicrobial stewardship programme in Sri Lanka: insights from early implementation experience (2024–2025)
-
9
[Articles] Antimicrobial susceptibility of priority bacterial pathogens from laboratory samples in Timor-Leste: a retrospective analysis of database (2020–2025)
-
10
[Articles] Mortality and cost of therapy of carbapenem susceptible vs resistant Gram-negative infections among hospitalised patients in India: a multicentric surveillance (2022–2025)
The Lancet Regional Health – Western Pacific
-
1
[Articles] Irritable bowel syndrome and suicide risk among adolescents: a prospective cohort study
-
2
[Corrections] Corrigendum to “HPV vaccination policies and implementation for adolescents in low- and middle-income countries: a scoping review” [The Lancet Regional Health-Western Pacific Volume 72, July (2026), 101919]
-
3
[Articles] Integrated environmental and nutritional efficiencies of local foods in Indonesia: a cradle-to-grave enviro-nutritional life cycle assessment
-
4
[Articles] Trends in Helicobacter pylori prevalence, force of infection, and attributable disease burden in China: a systematic review and Bayesian modelling study
-
5
[Articles] Family-centred, therapeutic camps for Aboriginal children with complex neurodevelopmental needs and early life trauma in remote Australia: a qualitative study of the Marurra-U family camp
-
6
[Comment] Compound climate extremes and “once-in-a-century” risk communication
-
7
[Articles] Validation of serological markers of recent exposure to Plasmodium vivax in Cambodia: a longitudinal cohort and cross-sectional study
-
8
[Articles] Cardiovascular magnetic resonance-based arrhythmogenic substrate assessment improves sudden cardiac death risk stratification in heart failure with mildly reduced ejection fraction: a multicenter retrospective observational study
-
9
[Articles] Projected preventable cancers through full implementation of tobacco control policies in East and South-East Asian countries, 2025–2050: a modeling study
-
10
[Articles] Priority assessment of antimicrobial-resistant pathogens in the Republic of Korea: a multicriteria decision analysis
The Lancet Respiratory Medicine
-
1
[Editorial] The far-reaching effects of wildfire smoke
-
2
[Comment] Beyond efficacy: registries, equity, and outcomes in the ETI era
-
3
[Articles] Clinical characteristics and outcomes in the adult cystic fibrosis population in Europe from 2014 to 2024: analysis of the European Cystic Fibrosis Society Patient Registry
-
4
[Comment] Rheumatoid arthritis-associated interstitial lung disease: between evidence, expertise, and guidelines
-
5
[Position Paper] Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment—an expert group consensus statement
-
6
[Articles] Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial
-
7
[Comment] Sugammadex versus neostigmine and postoperative pulmonary complications: a word of caution
-
8
[Comment] Pulmonary fibrosis in chILD: bridging the gap
-
9
[Articles] Prevalence and disease trajectories of pulmonary fibrosis of childhood interstitial lung disease: a register-based, multicentre observational study
-
10
[News] RSV vaccination and immunisation programmes accelerating worldwide
The Lancet Rheumatology
-
1
[Correspondence] The GO TEST Overture Trial: is the evidence sufficient to guide primary care practice? – Authors' reply
-
2
[Viewpoint] Addressing the urgent need for clinical trials in chronic non-bacterial osteomyelitis
-
3
[Correspondence] The GO TEST Overture Trial: is the evidence sufficient to guide primary care practice?
-
4
[Correspondence] The GO TEST Overture Trial: is the evidence sufficient to guide primary care practice?
-
5
[News] Research in Brief
-
6
[Editorial] Translating progress into patient benefit in dermatomyositis
-
7
[Correspondence] The GO TEST Overture Trial: is the evidence sufficient to guide primary care practice?
-
8
[Correspondence] Low-dose and very low-dose glucocorticoids: which low is low risk? – Authors’ reply
-
9
[Correspondence] Low-dose and very low-dose glucocorticoids: which low is low risk?
-
10
[Articles] Secukinumab biosimilar BAT2306 versus reference secukinumab in patients with moderate-to-severe plaque psoriasis: a multicentre, double-blind, randomised, active-controlled, phase 3 trial
eClinicalMedicine
-
1
[Viewpoint] The clinical consequences of excessive caution: rethinking how cancer screening policy is made
-
2
[Articles] Outcome at ten years of children born preterm: the EPIPAGE-2 and ELFE cohort studies
-
3
[News] European society of cardiology congress 2026
-
4
[Articles] ‘Virtual’ fracture clinic pathway for patients with simple fractures (RECITAL): a non-inferiority, randomised controlled trial
-
5
[Articles] Effects of oral salbutamol treatment on motor function and muscle strength in congenital myopathies (COMPIS): a single-centre, randomised, open-label, blinded-endpoint, crossover trial in Sweden
-
6
[Comment] Expression of concern—COVID-19: rapid antigen detection for SARS-CoV-2 by lateral flow assay: a national systematic evaluation of sensitivity and specificity for mass-testing
-
7
[Articles] Short, animated storytelling social contact videos reduce addiction stigma in the UK, USA, and South Africa: a randomised controlled trial of 13,397 participants
-
8
[Articles] A core outcome set for the wellbeing of healthcare professionals: an international Delphi consensus study
-
9
[Articles] Sex differences in tuberculosis incidence: a pooled analysis of 11 prospective cohort studies
-
10
[News] ESMO gynaecological cancers congress 2026
The Lancet
-
1
[Articles] Switch to injectable cabotegravir–rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial
-
2
[Lecture] Precision prevention and early detection: framework for a new clinical cancer control pathway
-
3
[Correspondence] Enhancing preparedness for the impending super El Niño
-
4
[Comment] The Accra Reset must turn sovereignty into country power
-
5
[Review] Wildfire smoke and health: current evidence, mechanisms, and future challenges
-
6
[Comment] Global health reform is missing a generation
-
7
[World Report] ALIMA: the NGO doing things differently
-
8
[Comment] The US opioid epidemic at a turning point
-
9
[Comment] The WHS Academic Alliance–Lancet Commission on academic responsibility for trust in science and societal change
-
10
[Comment] Perioperative immunotherapy goes global in gastro-oesophageal cancer
The Lancet Child & Adolescent Health
-
1
[Articles] Health service use of young people after mental health admission far from home: a retrospective cohort study in England
-
2
[Articles] Immunogenicity up to age 5 years following a single-dose or two-dose infant primary series of 10-valent or 13-valent pneumococcal conjugate vaccine each followed by a booster dose in South Africa: extended follow-up of a single-centre, open-lab
-
3
[Health Policy] Opportunities for advancing paediatric medical device access: regulatory frameworks in the EU and USA
-
4
[Articles] Injury burden among adolescents and young adults aged 10–24 years in the Arab region, 1990–2023: a systematic analysis of the Global Burden of Disease Study 2023
-
5
[Comment] An injury burden crisis among young people in the Arab region
-
6
[Comment] The pathogenic illusion of youth incarceration: a call for abolition medicine in Europe
-
7
[Comment] An urgent opportunity to ensure children's access to oral post-exposure prophylaxis trials for Bundibugyo virus disease
-
8
[Articles] Comparative effectiveness of clarithromycin and azithromycin for pertussis in hospitalised infants in Italy: a multicentre target trial emulation study
-
9
[Review] Methylation profile scores in child and adolescent health: a practical guide
-
10
[Health Policy] A global policy content analysis of congenital heart disease in national health priorities
The Lancet Diabetes & Endocrinology
-
1
[Corrections] Correction to Lancet Diabetes Endocrinol 2026; 14: 149–56
-
2
[Review] Hypoparathyroidism: translating science from the laboratory to the clinic
-
3
[Articles] Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case–control study
-
4
[Review] From adiposity to multisystem morbidity: the case for weight loss as disease modification
-
5
[Correspondence] Time for personalised incretin titration
-
6
[Comment] The glucagon renaissance in obesity therapeutics
-
7
[Articles] Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial
-
8
[Editorial] Diabetes in a warming world
-
9
[Comment] Safety and tolerability of orforglipron in Japanese people with type 2 diabetes
-
10
[Articles] Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial
The Lancet Gastroenterology & Hepatology
-
1
[Articles] Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial
-
2
[Correspondence] Incidence of inflammatory bowel disease in Jakarta, Indonesia, 2021–24
-
3
[Articles] Germline multigene panel testing for colorectal cancer: a systematic review and meta-analysis
-
4
[Articles] On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial
-
5
[Articles] ALG-055009 in non-cirrhotic adults with metabolic dysfunction-associated steatohepatitis (HERALD): a randomised, double-blind, placebo-controlled, phase 2a trial
-
6
[Review] The trajectory of inflammatory bowel disease in east and southeast Asia: transitioning from acceleration in incidence to compounding prevalence
-
7
[Comment] Propelling MASLD trials into the era of non-invasive tests
-
8
[Review] Bowel endometriosis: from pathogenesis to clinical management
-
9
[Review] Barrier restoration as a therapeutic strategy for disorders of gut–brain interaction
-
10
[Articles] Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre, open-label, randomised controlled superiority trial